Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,200 JPY | -0.78% | -1.23% | +25.98% |
13/05 | Jefferies Adjusts CKD'S Price Target to 3,700 Yen From 4,000 Yen, Keeps at Buy | MT |
15/04 | AstraZeneca: expects a sharp rise in kidney disease | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.98% | 137.91Cr | |
+1.61% | 1.54TCr | |
+30.43% | 531.1Cr | |
+3.83% | 517.96Cr | |
-19.02% | 445.56Cr | |
+14.49% | 439.22Cr | |
+16.57% | 397.95Cr | |
+45.02% | 386.58Cr | |
+2.23% | 336.51Cr | |
-3.82% | 315.85Cr |
- Stock Market
- Equities
- 6407 Stock
- News CKD Corporation
- Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD